These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
263 related articles for article (PubMed ID: 33720944)
41. Dynamic changes of D-dimer and neutrophil-lymphocyte count ratio as prognostic biomarkers in COVID-19. Ye W; Chen G; Li X; Lan X; Ji C; Hou M; Zhang D; Zeng G; Wang Y; Xu C; Lu W; Cui R; Cai Y; Huang H; Yang L Respir Res; 2020 Jul; 21(1):169. PubMed ID: 32620118 [TBL] [Abstract][Full Text] [Related]
42. First results of the "Lean European Open Survey on SARS-CoV-2-Infected Patients (LEOSS)". Jakob CEM; Borgmann S; Duygu F; Behrends U; Hower M; Merle U; Friedrichs A; Tometten L; Hanses F; Jung N; Rieg S; Wille K; Grüner B; Klinker H; Gersbacher-Runge N; Hellwig K; Eberwein L; Dolff S; Rauschning D; von Bergwelt-Baildon M; Lanznaster J; Strauß R; Trauth J; de With K; Ruethrich M; Lueck C; Nattermann J; Tscharntke L; Pilgram L; Fuhrmann S; Classen A; Stecher M; Schons M; Spinner C; Vehreschild JJ Infection; 2021 Feb; 49(1):63-73. PubMed ID: 33001409 [TBL] [Abstract][Full Text] [Related]
43. [Value of neutrophil-to-lymphocyte ratio in the classification diagnosis of coronavirus disease 2019]. Fei M; Tong F; Tao X; Wang J Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 May; 32(5):554-558. PubMed ID: 32576346 [TBL] [Abstract][Full Text] [Related]
44. Hematological and biochemical parameters as diagnostic and prognostic markers in SARS-COV-2 infected patients of Pakistan: a retrospective comparative analysis. Khalid A; Ali Jaffar M; Khan T; Abbas Lail R; Ali S; Aktas G; Waris A; Javaid A; Ijaz N; Muhammad N Hematology; 2021 Dec; 26(1):529-542. PubMed ID: 34334100 [No Abstract] [Full Text] [Related]
45. The clinical implication of dynamic neutrophil to lymphocyte ratio and D-dimer in COVID-19: A retrospective study in Suzhou China. Fu J; Kong J; Wang W; Wu M; Yao L; Wang Z; Jin J; Wu D; Yu X Thromb Res; 2020 Aug; 192():3-8. PubMed ID: 32407937 [TBL] [Abstract][Full Text] [Related]
46. Role of neutrophil-to-lymphocyte, lymphocyte-to-monocyte and platelet-to-lymphocyte ratios as predictors of disease severity in COVID-19 patients. Kalabin A; Mani VRK; Valdivieso SC; Donaldson B Infez Med; 2021 Mar; 29(1):46-53. PubMed ID: 33664172 [TBL] [Abstract][Full Text] [Related]
47. Demographics, clinical characteristics, and outcomes of 27,256 hospitalized COVID-19 patients in Kermanshah Province, Iran: a retrospective one-year cohort study. Hesni E; Sayad B; Khosravi Shadmani F; Najafi F; Khodarahmi R; Rahimi Z; Bozorgomid A; Sayad N BMC Infect Dis; 2022 Mar; 22(1):319. PubMed ID: 35361161 [TBL] [Abstract][Full Text] [Related]
48. The applicability of basic preventive measures of the pandemic COVID-19 and associated factors among residents in Guraghe Zone. Dessu S; Tsehay T; Girum T; Timerga A; Solomon M; Tsegaye B; Geremew M; Migora B; Mesfin Y; Kemal A; Alebel F; Tolosa O; Tesfa S; Yasin F PLoS One; 2021; 16(8):e0256598. PubMed ID: 34432844 [TBL] [Abstract][Full Text] [Related]
49. Facemask-wearing behavior to prevent COVID-19 and associated factors among public and private bank workers in Ethiopia. Hassen S; Adane M PLoS One; 2021; 16(12):e0259659. PubMed ID: 34851973 [TBL] [Abstract][Full Text] [Related]
50. Clinical characteristics and laboratory features of COVID-19 in high altitude areas: A retrospective cohort study. Chen H; Qin L; Wu S; Xu W; Gao R; Zhang X PLoS One; 2021; 16(5):e0249964. PubMed ID: 34003821 [TBL] [Abstract][Full Text] [Related]
51. The neutrophil/lymphocyte ratio as a prognostic factor in COVID-19 patients: a case-control study. La Torre G; Marte M; Massetti AP; Carli SM; Romano F; Mastroianni CM; Minorenti M; Alessandri F; Ajassa C; Fusconi M; De Vincentiis M; de Meo D; Villani C; Cardi M; Pugliese F; Eur Rev Med Pharmacol Sci; 2022 Feb; 26(3):1056-1064. PubMed ID: 35179773 [TBL] [Abstract][Full Text] [Related]
52. Predictive value of the neutrophil to lymphocyte ratio for disease deterioration and serious adverse outcomes in patients with COVID-19: a prospective cohort study. Zeng ZY; Feng SD; Chen GP; Wu JN BMC Infect Dis; 2021 Jan; 21(1):80. PubMed ID: 33461497 [TBL] [Abstract][Full Text] [Related]
53. Clinical Features of Patients Infected With Coronavirus Disease 2019 With Elevated Liver Biochemistries: A Multicenter, Retrospective Study. Fu Y; Zhu R; Bai T; Han P; He Q; Jing M; Xiong X; Zhao X; Quan R; Chen C; Zhang Y; Tao M; Yi J; Tian D; Yan W Hepatology; 2021 Apr; 73(4):1509-1520. PubMed ID: 32602604 [TBL] [Abstract][Full Text] [Related]
54. Risk factors for developing severe COVID-19 in China: an analysis of disease surveillance data. Geng MJ; Wang LP; Ren X; Yu JX; Chang ZR; Zheng CJ; An ZJ; Li Y; Yang XK; Zhao HT; Li ZJ; He GX; Feng ZJ Infect Dis Poverty; 2021 Apr; 10(1):48. PubMed ID: 33845915 [TBL] [Abstract][Full Text] [Related]
55. A new haematocytometric index: Predicting severity and mortality risk value in COVID-19 patients. Kilercik M; Demirelce Ö; Serdar MA; Mikailova P; Serteser M PLoS One; 2021; 16(8):e0254073. PubMed ID: 34351940 [TBL] [Abstract][Full Text] [Related]
56. Risk Factors of Outcomes of COVID-19 Patients in Korea: Focus on Early Symptoms. Jang SY; Seon JY; Eun BL; Koh SB; Yoo JH; Lee WY; Yum HK; Yoon SJ; Oh IH; Bae SC; Chang SG J Korean Med Sci; 2021 May; 36(18):e132. PubMed ID: 33975399 [TBL] [Abstract][Full Text] [Related]
58. The value of clinical parameters in predicting the severity of COVID-19. Shang W; Dong J; Ren Y; Tian M; Li W; Hu J; Li Y J Med Virol; 2020 Oct; 92(10):2188-2192. PubMed ID: 32436996 [TBL] [Abstract][Full Text] [Related]
59. Basoglu OK; Ozhan MH; Ekren PK; Ak G; Tasbakan MS; Sayiner A Ann Clin Lab Sci; 2020 Nov; 50(6):848-851. PubMed ID: 33334804 [TBL] [Abstract][Full Text] [Related]
60. Outcomes of COVID-19 Among Hospitalized Health Care Workers in North America. Yang JY; Parkins MD; Canakis A; Aroniadis OC; Yadav D; Dixon RE; Elmunzer BJ; Forbes N; JAMA Netw Open; 2021 Jan; 4(1):e2035699. PubMed ID: 33507259 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]